Anuncio • Mar 27
Essity AB (Publ) Approves Dividend for the Financial Year 2025 Essity AB (publ) at its Annual General Meeting held on March 26, 2026 declared a dividend for the financial year 2025 of SEK 8.75 per share. Record date for the dividend is set to March 30, 2026. Anuncio • Mar 03
Essity Announces Executive Changes Essity has appointed Niklas Westin Sundberg as Chief Digital & Information Officer. He will succeed Carl-Magnus Månsson, who is leaving Essity to take up a new external role. Niklas will become a member of the Executive Management Team and be responsible for the company's continued digital transformation and the Digital Transformation and Business Enablement function. With more than 20 years of experience in digital development in international and complex organizations, Niklas Westin Sundberg has led business-driven IT strategies, cybersecurity work and AI initiatives at global companies such as Kuehne+Nagel and ASSA ABLOY. Niklas Westin Sundberg will take office on April 15, 2026 and will report directly to Ulrika Kolsrud, President and CEO of Essity. Anuncio • Feb 03
Essity AB (publ) (OM:ESSITY B) completed the acquisition of Feminine care business from Edgewell Personal Care Company (NYSE:EPC). Essity AB (publ) (OM:ESSITY B) entered into a definitive agreement to acquire Feminine care business from Edgewell Personal Care Company (NYSE:EPC) for $340 million on November 12, 2025. The feminine care business includes Playtex®, Stayfree®, Carefree® and o.b.® and Edgewell Personal Care Company will classify the Feminine Care business as discontinued operations in the beginning of first quarter of 2026. Pursuant to the terms of the Purchase Agreement, the Edgewell Personal Care Company is entitled to receive a termination fee of $15 million from Essity AB. if the Purchase Agreement is terminated under certain circumstances.
The transaction is expected to close in the first quarter of calendar 2026, subject to customary closing conditions, including the receipt of required regulatory approvals. Edgewell Personal Care Company intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet while continuing to invest in the long-term growth of its core businesses.
Latham & Watkins LLP acted as legal advisor and Perella Weinberg Partners LP acted as financial advisor for Edgewell Personal Care Company. Morgan Stanley AB acted as financial advisor to Essity AB (publ).
Essity AB (publ) (OM:ESSITY B) completed the acquisition of Feminine care business from Edgewell Personal Care Company (NYSE:EPC) on February 2, 2026. Anuncio • Jan 08
Funds Discontinue Legal Action Against Essity over Bond Loans in English Courts The funds that have brought an action against Essity in the English courts regarding bond loans issued by the company have chosen to discontinue their action. The case is therefore closed. On October 17, 2024, Essity announced that the company had received a request for early redemption from certain investors regarding bonds maturing in 2029, 2030 and 2031, respectively. In December 2024, the funds initiated proceedings against Essity in the English courts. The parties have entered into an agreement with conditions, among other things, that they have no claims against each other due to Essity's sale of its shares in Vinda. The funds subsequently discontinued their action before the court. Essity has not changed its view that the action was unfounded and has not paid the funds or otherwise compensated them in the dispute. Anuncio • Nov 13
Essity AB (publ) (OM:ESSITY B) entered into a definitive agreement to acquire Feminine care business from Edgewell Personal Care Company (NYSE:EPC) for $340 million. Essity AB (publ) (OM:ESSITY B) entered into a definitive agreement to acquire Feminine care business from Edgewell Personal Care Company (NYSE:EPC) for $340 million on November 12, 2025. The feminine care business includes Playtex®, Stayfree®, Carefree® and o.b.® and Edgewell Personal Care Company will classify the Feminine Care business as discontinued operations in the beginning of first quarter of 2026 and intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet while continuing to invest in the long-term growth of its core businesses. Pursuant to the terms of the Purchase Agreement, the Company is entitled to receive a termination fee of $15 million from Essity AB. if the Purchase Agreement is terminated under certain circumstances
The transaction is expected to close in the first quarter of calendar 2026, subject to customary closing conditions, including the receipt of required regulatory approvals.
Latham & Watkins LLP acted as legal advisor and Perella Weinberg Partners LP acted as financial advisor for Edgewell Personal Care Company. Morgan Stanley AB acted as financial advisor to Essity AB (publ). Anuncio • Sep 20
Donato Giorgio Leaves as President Global Supply Chain and Member of the Executive Management Team of Essity, Effective October 31, 2025 Essity announced that Donato Giorgio, President Global Supply Chain and member of the Executive Management Team, will leave the company. Donato Giorgio joined Essity in 2009 and has held various leadership positions within Essity's global manufacturing and supply chain. In 2015, he became a member of the Executive Management Team and under his leadership, the company has developed its sustainable manufacturing and circular resource solutions. Donato Giorgio will leave his position on October 31, 2025. The recruitment process for his successor has been initiated. Anuncio • Aug 16
Essity Appoints Anand Chandarana as President of Business Unit Health & Medical, Effective from September 1, 2025 Essity announced appointment ofAnand Chandarana as President of Business Unit Health & Medical. He will assume the role on September 1, 2025, and will also join the company’s Executive Management Team. Anand Chandarana has been with Essity and the business unit Health & Medical since 2020, most recently as Vice President Commercial Development. He has previously worked 17 years and held several senior positions at the medical solutions company Mölnlycke Health Care. Anand Chandarana will report to Ulrika Kolsrud, President and CEO of Essity. He is a citizen of both the UK and Sweden and will be based in Gothenburg. Business Unit Health & Medical offers products and solutions under the categories Incontinence Products Health Care, Wound Care, Compression therapy and Orthopedics under leading brands such as TENA, Leukoplast, Cutimed, Hydrofera BLUE, JOBST, Delta-Cast, and Actimove. Anuncio • Apr 29
Essity AB (publ) (OM:ESSITY B) commences an Equity Buyback Plan for 60,946,249 shares, representing 8.79% of its issued share capital, under the authorization approved on March 27, 2025. Essity AB (publ) (OM:ESSITY B) commences share repurchases on April 24, 2025, under the program mandated by the shareholders in the Annual General Meeting held on March 27, 2025. As per the mandate, the company is authorized to repurchase up to 60,946,249 B shares, representing 8.79% of its issued share capital. The shares shall be repurchased such that the company does not hold more than 10% of its issued share capital. The shares will be repurchased at a price on Nasdaq Stockholm at a price within the at each time prevailing price interval for the share on the marketplace, meaning the interval between the highest purchase price and the lowest selling price. The purpose of the proposed authorization is to be able to adapt the company’s capital structure. The repurchased shares will be used as payment or financing on account of acquisitions of companies or businesses, and thereby contribute to increased shareholder value. The program will be valid until the Annual General Meeting in 2026. As of February 20, 2025, the company had 702,342,489 issued shares consisting of 58,973,654 are class A shares and 643,368,835 are class B shares including 9,288,000 B shares in treasury.
On April 23, 2025, the company announced a share repurchase program. Under the program, the company will repurchase up to SEK 3,000 million worth of its B shares. The repurchased shares are expected to be cancelled. The share repurchase will be financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of the company’s capital allocation. The repurchases will commence from April 24, 2025, and will be valid till Annual General Meeting of 2026. Anuncio • Mar 24
Essity AB (publ) to Report Q1, 2025 Results on Apr 24, 2025 Essity AB (publ) announced that they will report Q1, 2025 results at 7:00 AM, Central European Standard Time on Apr 24, 2025 Anuncio • Feb 22
Essity AB (publ), Annual General Meeting, Mar 27, 2025 Essity AB (publ), Annual General Meeting, Mar 27, 2025, at 14:00 W. Europe Standard Time. Location: at stockholm waterfront congress centre, nils ericsons plan 4, stockholm Sweden Anuncio • Feb 21
Essity AB (publ) Announces Ewa Björling Declines Re-Election as Director Essity AB (publ) at its Annual General Meeting to be held on 27 March 2025, announced Ewa Björling has declined re-election as director. Anuncio • Dec 17
Essity Receives Information on Proceedings Initiated by Minority of Investors, in Some of Its Luxembourg-Listed Bond Series in English Court on December 16, 2024, Essity has received information that a minority of investors, in some of its Luxembourg-listed bond series, have initiated proceedings in English court. Referring to the release dated October 17, 2024, regarding demands from a few bondholders and bonds issued by Essity, the company has been made aware that some of these investors have initiated proceedings in an English court. The investors' holdings represent a small portion of the outstanding bonds. As previously communicated, Essity rejects the claim that there is a right to early repayment under the terms of these bonds and considers the demand to be unfounded. Anuncio • Oct 18
Essity Receives Demand for Early Repayment of Bonds Essity has received a demand for early payment from a few bondholders regarding bonds maturing in 2029, 2030 and 31. Essity disputes the demand. The demand refers to a minority part of the total amount of the bonds with these maturing dates. These bondholders claim that an Event of Default has occurred under the terms. As previously stated, Essity is confident, after having obtained professional advice, that an Event of Default has not occurred and that the demand is unfounded. Anuncio • Apr 27
Essity AB (publ) to Report Fiscal Year 2024 Results on Jan 23, 2025 Essity AB (publ) announced that they will report fiscal year 2024 results on Jan 23, 2025 Anuncio • Jan 25
Essity AB (publ) Proposes Dividend for the Year 2023, Payable on March 28, 2024 Essity AB (publ) proposed an increase in the dividend of 7% to SEK 7.75 (7.25) per share for the year 2023. March 25, 2024, is proposed as the record date for the right to receive dividends, and the dividend is expected to be paid on March 28, 2024. Anuncio • Nov 08
Essity Launches Caressa - Digital Platform to Assist Family Carers Essity launched Caressa - a digital platform to assist family caregivers. To address the growing needs of family caregivers, the hygiene and health company Essity is launching the AgeTech-s solution Caressa, aimed at providing necessary support for the essential aspects of care. Caressa is a digital platform and new business model for Essity that brings together care essentials - tasks, medications and appointments - into one subscription-based app, enabling multiple family members to collaborate and coordinate the care of a loved one. With this launch, Essity is expanding its offering in the field of AgeTech, a rapidly growing sector driven by the combination of an aging population and advancements in technology, projected to reach a value of USD 2.7 trillion by 2025. Caressa adds to previous digital solutions from Essity such as TENA SmartCare that offers digital solutions for continence management, and Cutimed Wound Navigator that provides support in assessing and documenting wounds. The global demographic shift, with a rapidly growing older population, reveals an opportunity for new practices and innovation within the care economy to make a significant positive impact. A global survey of 15,000 respondents conducted by Essity reveals how 61% agree that digital healthcare and services save time for caregivers, which they can subsequently spend with patients. Anuncio • Nov 02
Essity AB (publ) to Report Q4, 2023 Results on Feb 26, 2024 Essity AB (publ) announced that they will report Q4, 2023 results on Feb 26, 2024 Anuncio • Oct 24
Essity Aktiebolag (Publ) Announces Current Chairman of the Board, Pär Boman, Declined Re-Election Essity Aktiebolag (publ) announced, Essity's current Chairman of the Board, Pär Boman, has declined re-election. Anuncio • Sep 22
Essity Chairman Pär Boman Declines Re-Election Pär Boman has declined re-election as Chairman of Essity's Board of Directors. He will remain as Chairman of the Board until March 2024. Anuncio • Aug 11
Essity Appoints Sandra Åberg as Head of Investor Relations, Effective September 1, 2023 Essity has appointed Sandra Åberg as Vice President and Head of Investor Relations, effective September 1, 2023. Sandra is currently Director Investor Relations at Essity. The current Head of Investor Relations, Johan Karlsson, will assume the role of Vice President Business Control at Essity. Sandra Åberg has been part of the Investor Relations team at Essity since the listing in 2017. After beginning her career at Bain & Company, Sandra has also worked at SEB and SCA. She holds an Msc in Business Administration and Economics from Stockholm University. Anuncio • Jul 18
New Technologies LLC acquired Russian operations from Essity AB (publ) (OM:ESSITY B) for SEK 1.2 billion. New Technologies LLC agreed to acquire Russian operations from Essity AB (publ) (OM:ESSITY B) for SEK 1.2 billion on June 10, 2023. The transaction is expected to be finalized during the second quarter of 2023. JPMorgan Chase & Co. (NYSE:JPM) acted as a financial advisor to Essity AB.
New Technologies LLC completed the acqusiiiton of Russian operations from Essity AB (publ) (OM:ESSITY B) on July 17, 2023. Anuncio • Jun 14
Essity Announces the Launch of Sensitive Caretm Pads Essity announced the launch of Sensitive CareTM Pads, the first ever bladder weakness pads enriched with its gentle SkinComfort Formula. TENA Sensitive Care Pads are now available in-store and online at retailers across the U.S. TENA Sensitive Care Pads deliver the same triple protection from leaks, odor and moisture and are dermatologically approved by the Skin Health Alliance. With cushiony foam side barriers, Duolock® core, and a secure comfortable fit, TENA Sensitive Care Pads offer the ultimate protection for women with incontinence. At varying levels of absorbency and protection, TENA has a full line of incontinence protection products to meet the needs of all individuals. No matter the need – from light bladder drips and dribbles, heavy leakage or overnight protection for worry free nights – all TENA products can be found at your local mass retailer, grocery or drug store, online. Anuncio • Jun 12
An unknown buyer agreed to acquire Russian operations from Essity AB (publ) (OM:ESSITY B). An unknown buyer agreed to acquire Russian operations from Essity AB (publ) (OM:ESSITY B) on June 10, 2023. The transaction is expected to be finalized during the second quarter of 2023. Anuncio • Aug 19
Essity AB (publ) to Report Fiscal Year 2022 Final Results on Mar 01, 2023 Essity AB (publ) announced that they will report fiscal year 2022 final results on Mar 01, 2023 Anuncio • Apr 22
Essity AB (publ) to Report Fiscal Year 2022 Results on Jan 26, 2023 Essity AB (publ) announced that they will report fiscal year 2022 results on Jan 26, 2023 
